Cargando…
Totality of evidence of the effectiveness of repurposed therapies for COVID‐19: Can we use real‐world studies alongside randomized controlled trials?
Rapid and robust strategies to evaluate the efficacy and effectiveness of novel and existing pharmacotherapeutic interventions (repurposed treatments) in future pandemics are required. Observational “real‐world studies” (RWS) can report more quickly than randomized controlled trials (RCTs) and would...
Autores principales: | Mandema, Jaap, Montgomery, Hugh, Dron, Louis, Fu, Shuai, Russek‐Cohen, Estelle, Bromley, Christina, Mouksassi, Samer, Lalonde, Amy, Springford, Aaron, Tsai, Larry, Ambery, Phil, McNair, Doug, Qizilbash, Nawab, Pocock, Stuart, Zariffa, Névine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582658/ https://www.ncbi.nlm.nih.gov/pubmed/37466279 http://dx.doi.org/10.1111/cts.13591 |
Ejemplares similares
-
Vaccines After an Emergency Use Authorization (EUA): Modern Evidence Generation Approaches
por: Zariffa, Névine, et al.
Publicado: (2021) -
Data capture and sharing in the COVID-19 pandemic: a cause for concern
por: Dron, Louis, et al.
Publicado: (2022) -
Trends in utilization and off-label use of polyethylene glycol 4000 laxatives and the prevalence of constipation in children in France
por: Qizilbash, Nawab, et al.
Publicado: (2011) -
Open Science to Address COVID-19: Sharing Data to Make Our Research Investment Go Further
por: Zariffa, Névine, et al.
Publicado: (2020) -
Real world safety of methoxyflurane analgesia in the emergency setting: a comparative hybrid prospective-retrospective post-authorisation safety study
por: Qizilbash, Nawab, et al.
Publicado: (2023)